UBS Group’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $400M | Sell |
|
|||||
|
2025
Q1 | $482M | Buy |
|
|||||
|
2024
Q4 | $404M | Buy |
|
|||||
|
2024
Q3 | $450M | Buy |
|
|||||
|
2024
Q2 | $419M | Buy |
|
|||||
|
2024
Q1 | $376M | Buy |
|
|||||
|
2023
Q4 | $239M | Sell |
|
|||||
|
2023
Q3 | $245M | Sell |
|
|||||
|
2023
Q2 | $269M | Buy |
|
|||||
|
2023
Q1 | $212M | Sell |
|
|||||
|
2022
Q4 | $232M | Buy |
|
|||||
|
2022
Q3 | $189M | Sell |
|
|||||
|
2022
Q2 | $252M | Sell |
|
|||||
|
2022
Q1 | $261M | Buy |
|
|||||
|
2021
Q4 | $292M | Buy |
|
|||||
|
2021
Q3 | $252M | Sell |
|
|||||
|
2021
Q2 | $294M | Buy |
|
|||||
|
2021
Q1 | $247M | Sell |
|
|||||
|
2020
Q4 | $287M | Sell |
|
|||||
|
2020
Q3 | $306M | Buy |
|
|||||
|
2020
Q2 | $260M | Buy |
|
|||||
|
2020
Q1 | $219M | Buy |
|
|||||
|
2019
Q4 | $215M | Sell |
|
|||||
|
2019
Q3 | $236M | Sell |
|
|||||
|
2019
Q2 | $241M | Buy |
|
|||||
|
2019
Q1 | $220M | Sell |
|
|||||
|
2018
Q4 | $234M | Sell |
|
|||||
|
2018
Q3 | $975M | Buy |
|
|||||
|
2018
Q2 | $833M | Sell |
|
|||||
|
2018
Q1 | $977M | Buy |
|
|||||
|
2017
Q4 | $958M | Buy |
|
|||||
|
2017
Q3 | $776M | Sell |
|
|||||
|
2017
Q2 | $836M | Buy |
|
|||||
|
2017
Q1 | $788M | Buy |
|
|||||
|
2016
Q4 | $658M | Buy |
|
|||||
|
2016
Q3 | $730M | Buy |
|
|||||
|
2016
Q2 | $700M | Buy |
|
|||||
|
2016
Q1 | $658M | Sell |
|
|||||
|
2015
Q4 | $625M | Buy |
|
|||||
|
2015
Q3 | $589M | Buy |
|
|||||
|
2015
Q2 | $595M | Buy |
|
|||||
|
2015
Q1 | $600M | Buy |
|
|||||
|
2014
Q4 | $577M | Buy |
|